Skip to main content

Together we are beating cancer

Donate now

Prostate cancer

Around 47,700 men are diagnosed with prostate cancer in the UK each year, making it the most common cancer in men in the UK. It develops in the prostate, a walnut-sized gland found at the base of the bladder.
Showing 12 out of 233 results
Radiographer looking at a mammogram image

Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​. Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​.

by Amy Warnock | In depth | 1 October 2024

1 October 2024

Zhe Huang

We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer... We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer...

by Cancer Research UK | Interview | 10 September 2024

10 September 2024

Sample bottles in a lab

A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial. A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial.

by Tim Gunn | News | 1 June 2024

1 June 2024

A man talking to a GP

Why isn’t there a screening programme for prostate cancer? Here, we take a look at some of the latest research into PSA testing to find out.  Why isn’t there a screening programme for prostate cancer? Here, we take a look at some of the latest research into PSA testing to find out. 

by Amy Warnock | Analysis | 6 April 2024

6 April 2024

Prostate Cancer cell image taken using a Scanning Electron Microscope

Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes. Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes.

by Amy Warnock | News | 29 February 2024

29 February 2024

That Cancer Conversation in a white speech bubble with a dark blue background

In this episode of That Cancer Conversation, we're going to take you into the world of clinical research and walk you through the pathway to give you the full picture of what a clinical trial really involves.  In this episode of That Cancer Conversation, we're going to take you into the world of clinical research and walk you through the pathway to give you the full picture of what a clinical trial really involves. 

by Cancer Research UK | Podcast | 27 November 2023

27 November 2023

This entry is part 12 of 21 in the series That Cancer Conversation
Breast cancer cells

Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England.  Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England. 

by Tim Gunn | News | 11 April 2023

11 April 2023

A prostate cancer cell.

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

by Jacob Smith | News | 13 September 2022

13 September 2022

Photograph of a person having an MRI scan.

New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways. New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways.

by Lilly Matson | Analysis | 14 February 2022

14 February 2022

prostate cancer biopsy
  • Science & Technology
  • Health & Medicine

Targeted prostate cancer screening: Are we there yet?

Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet? Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?

by Katie Roberts | Analysis | 20 October 2021

20 October 2021